Skip to main content
Erschienen in: Archives of Dermatological Research 7/2010

01.09.2010 | Original Paper

A comparison of Ki-67 antigen presentation in acute generalized exanthematous pustulosis and pustular psoriasis

verfasst von: Shyue-Luen Chang, Sindy Hu, Shuen-Iu Hung, Yau-Li Huang, Wen-chin Hsiao, Wen-Hung Chung

Erschienen in: Archives of Dermatological Research | Ausgabe 7/2010

Einloggen, um Zugang zu erhalten

Abstract

Ki-67 is an established marker of cell proliferation. It is highly expressed in psoriasis and correlated with the clinical severity of psoriasis. Higher number of Ki-67 positive keratinocytes has been observed in pustular psoriasis (PP) as compared with psoriasis vulgaris. As for Acute generalized exanthematous pustulosis (AGEP), a distinct disease entity but similar in many aspects of clinicopathologic features to PP, Ki-67 immunostaining presentation has never been investigated before. This study aimed to compare Ki-67 immunostaining presentation between PP and AGEP. By immunohistochemical staining, we compared Ki-67 immunostaining presentation on skin lesions of five patients of AGEP and five age-matched patients of PP. Ki-67 positive keratinocytes were counted and mean values were determined to compare between PP and AGEP. An augmented presence of Ki-67 positive keratinocytes was found in both AGEP and PP and they distributed not only in basal cell layer but in middle or even upper part of epidermis. Statistical analysis using Mann–Whitney U test showed no difference of epidermal proliferation rate between the two groups (P = 0.222). The results showed there was no difference of Ki-67 immunostaining presentation between AGEP and PP. Besides, we found marked increase of Ki-67-positive proliferating keratinocytes in AGEP and suggested that epidermal hyperproliferation may also play an important role in the formation of AGEP. We also discussed the possible pathophysiology of AGEP, possible epidermal architecture changes in AGEP and PP, and found the similarity in pathophysiology of AGEP and PP.
Literatur
1.
Zurück zum Zitat Abou-Samra T, Constantin JM, Amarger S, Mansard S, Souteyrand P, Bazin JE, D’Incan M (2004) Generalized pustular psoriasis complicated by acute respiratory distress syndrome. Br J Dermatol 150:353–356CrossRefPubMed Abou-Samra T, Constantin JM, Amarger S, Mansard S, Souteyrand P, Bazin JE, D’Incan M (2004) Generalized pustular psoriasis complicated by acute respiratory distress syndrome. Br J Dermatol 150:353–356CrossRefPubMed
2.
Zurück zum Zitat Ando M, Kawashima T, Kobayashi H, Ohkawara A (1990) Immunohistological detection of proliferating cells in normal and psoriatic epidermis using ki-67 monoclonal antibody. J Dermatol Sci 1:441–446CrossRefPubMed Ando M, Kawashima T, Kobayashi H, Ohkawara A (1990) Immunohistological detection of proliferating cells in normal and psoriatic epidermis using ki-67 monoclonal antibody. J Dermatol Sci 1:441–446CrossRefPubMed
3.
Zurück zum Zitat Bovenschen HJ, Seyger MM, Van de Kerkhof PC (2005) Plaque psoriasis vs. Atopic dermatitis and lichen planus: a comparison for lesional t-cell subsets, epidermal proliferation and differentiation. Br J Dermatol 153:72–78CrossRefPubMed Bovenschen HJ, Seyger MM, Van de Kerkhof PC (2005) Plaque psoriasis vs. Atopic dermatitis and lichen planus: a comparison for lesional t-cell subsets, epidermal proliferation and differentiation. Br J Dermatol 153:72–78CrossRefPubMed
4.
Zurück zum Zitat Bovenschen HJ, Otero ME, Langewouters AM, van Vlijmen-Willems IM, van Rens DW, Seyger MM, van de Kerkhof PC (2007) Oral retinoic acid metabolism blocking agent rambazole for plaque psoriasis: An immunohistochemical study. Br J Dermatol 156:263–270CrossRefPubMed Bovenschen HJ, Otero ME, Langewouters AM, van Vlijmen-Willems IM, van Rens DW, Seyger MM, van de Kerkhof PC (2007) Oral retinoic acid metabolism blocking agent rambazole for plaque psoriasis: An immunohistochemical study. Br J Dermatol 156:263–270CrossRefPubMed
5.
Zurück zum Zitat Britschgi M, Steiner UC, Schmid S, Depta JP, Senti G, Bircher A, Burkhart C, Yawalkar N, Pichler WJ (2001) T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 107:1433–1441CrossRefPubMed Britschgi M, Steiner UC, Schmid S, Depta JP, Senti G, Bircher A, Burkhart C, Yawalkar N, Pichler WJ (2001) T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 107:1433–1441CrossRefPubMed
6.
Zurück zum Zitat Britschgi M, Pichler WJ (2002) Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by t cells. Curr Opin Allergy Clin Immunol 2:325–331CrossRefPubMed Britschgi M, Pichler WJ (2002) Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by t cells. Curr Opin Allergy Clin Immunol 2:325–331CrossRefPubMed
7.
Zurück zum Zitat Chen GS, Wu TM, Yang SA, Yu HS (2001) Quantitative assessments of physiological and biological parameters in psoriatic lesions and its correlations to the clinical severity of psoriasis. Kaohsiung J Med Sci 17:408–418PubMed Chen GS, Wu TM, Yang SA, Yu HS (2001) Quantitative assessments of physiological and biological parameters in psoriatic lesions and its correlations to the clinical severity of psoriasis. Kaohsiung J Med Sci 17:408–418PubMed
8.
Zurück zum Zitat Davidovici BB, Pavel D, Cagnano E, Rozenman D, Halevy S (2006) Acute generalized exanthematous pustulosis following a spider bite: Report of 3 cases. J Am Acad Dermatol 55:525–529CrossRefPubMed Davidovici BB, Pavel D, Cagnano E, Rozenman D, Halevy S (2006) Acute generalized exanthematous pustulosis following a spider bite: Report of 3 cases. J Am Acad Dermatol 55:525–529CrossRefPubMed
9.
Zurück zum Zitat Iizuka H, Honda H, Ishida-Yamamoto A (1997) Epidermal remodeling in psoriasis. II. A quantitative analysis of the epidermal architecture. J Invest Dermatol 109:806–810CrossRefPubMed Iizuka H, Honda H, Ishida-Yamamoto A (1997) Epidermal remodeling in psoriasis. II. A quantitative analysis of the epidermal architecture. J Invest Dermatol 109:806–810CrossRefPubMed
10.
Zurück zum Zitat Iizuka H, Takahashi H, Ishida-Yamamoto A (2003) Pathophysiology of generalized pustular psoriasis. Arch Dermatol Res 295(Suppl 1):S55–S59PubMed Iizuka H, Takahashi H, Ishida-Yamamoto A (2003) Pathophysiology of generalized pustular psoriasis. Arch Dermatol Res 295(Suppl 1):S55–S59PubMed
11.
Zurück zum Zitat Iizuka H, Takahashi H, Ishida-Yamamoto A (2004) Psoriatic architecture constructed by epidermal remodeling. J Dermatol Sci 35:93–99CrossRefPubMed Iizuka H, Takahashi H, Ishida-Yamamoto A (2004) Psoriatic architecture constructed by epidermal remodeling. J Dermatol Sci 35:93–99CrossRefPubMed
12.
Zurück zum Zitat Kastelan M, Prpic Massari L, Gruber F, Zamolo G, Zauhar G, Coklo M, Rukavina D (2004) Perforin expression is upregulated in the epidermis of psoriatic lesions. Br J Dermatol 151:831–836CrossRefPubMed Kastelan M, Prpic Massari L, Gruber F, Zamolo G, Zauhar G, Coklo M, Rukavina D (2004) Perforin expression is upregulated in the epidermis of psoriatic lesions. Br J Dermatol 151:831–836CrossRefPubMed
13.
Zurück zum Zitat Keller M, Spanou Z, Schaerli P, Britschgi M, Yawalkar N, Seitz M, Villiger PM, Pichler WJ (2005) T cell-regulated neutrophilic inflammation in autoinflammatory diseases. J Immunol 175:7678–7686PubMed Keller M, Spanou Z, Schaerli P, Britschgi M, Yawalkar N, Seitz M, Villiger PM, Pichler WJ (2005) T cell-regulated neutrophilic inflammation in autoinflammatory diseases. J Immunol 175:7678–7686PubMed
14.
Zurück zum Zitat Lowes MA, Lew W, Krueger JG (2004) Current concepts in the immunopathogenesis of psoriasis. Dermatol Clin 22:349–369 (vii)CrossRefPubMed Lowes MA, Lew W, Krueger JG (2004) Current concepts in the immunopathogenesis of psoriasis. Dermatol Clin 22:349–369 (vii)CrossRefPubMed
15.
Zurück zum Zitat Margulis V, Shariat SF, Ashfaq R, Sagalowsky AI, Lotan Y (2006) Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease. Clin Cancer Res 12:7369–7373CrossRefPubMed Margulis V, Shariat SF, Ashfaq R, Sagalowsky AI, Lotan Y (2006) Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease. Clin Cancer Res 12:7369–7373CrossRefPubMed
16.
Zurück zum Zitat Matsuta M, Kimura S, Kosegawa G, Kon S, Matsuta M (1996) Immunohistochemical detection of ki-67 in epithelial skin tumors in formalin-fixed paraffin-embedded tissue sections using a new monoclonal antibody (mib-1). J Dermatol 23:147–152PubMed Matsuta M, Kimura S, Kosegawa G, Kon S, Matsuta M (1996) Immunohistochemical detection of ki-67 in epithelial skin tumors in formalin-fixed paraffin-embedded tissue sections using a new monoclonal antibody (mib-1). J Dermatol 23:147–152PubMed
17.
Zurück zum Zitat Roujeau JC, Bioulac-Sage P, Bourseau C, Guillaume JC, Bernard P, Lok C, Plantin P, Claudy A, Delavierre C, Vaillant L et al (1991) Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 127:1333–1338CrossRefPubMed Roujeau JC, Bioulac-Sage P, Bourseau C, Guillaume JC, Bernard P, Lok C, Plantin P, Claudy A, Delavierre C, Vaillant L et al (1991) Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 127:1333–1338CrossRefPubMed
18.
Zurück zum Zitat Schaerli P, Britschgi M, Keller M, Steiner UC, Steinmann LS, Moser B, Pichler WJ (2004) Characterization of human t cells that regulate neutrophilic skin inflammation. J Immunol 173:2151–2158PubMed Schaerli P, Britschgi M, Keller M, Steiner UC, Steinmann LS, Moser B, Pichler WJ (2004) Characterization of human t cells that regulate neutrophilic skin inflammation. J Immunol 173:2151–2158PubMed
19.
Zurück zum Zitat Schmid S, Kuechler PC, Britschgi M, Steiner UC, Yawalkar N, Limat A, Baltensperger K, Braathen L, Pichler WJ (2002) Acute generalized exanthematous pustulosis: role of cytotoxic t cells in pustule formation. Am J Pathol 161:2079–2086PubMed Schmid S, Kuechler PC, Britschgi M, Steiner UC, Yawalkar N, Limat A, Baltensperger K, Braathen L, Pichler WJ (2002) Acute generalized exanthematous pustulosis: role of cytotoxic t cells in pustule formation. Am J Pathol 161:2079–2086PubMed
20.
Zurück zum Zitat Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC (2001) Acute generalized exanthematous pustulosis (AGEP)—a clinical reaction pattern. J Cutan Pathol 28:113–119CrossRefPubMed Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC (2001) Acute generalized exanthematous pustulosis (AGEP)—a clinical reaction pattern. J Cutan Pathol 28:113–119CrossRefPubMed
21.
Zurück zum Zitat Soini Y, Kamel D, Paakko P, Lehto VP, Oikarinen A, Vahakangas KV (1994) Aberrant accumulation of p53 associates with ki67 and mitotic count in benign skin lesions. Br J Dermatol 131:514–520CrossRefPubMed Soini Y, Kamel D, Paakko P, Lehto VP, Oikarinen A, Vahakangas KV (1994) Aberrant accumulation of p53 associates with ki67 and mitotic count in benign skin lesions. Br J Dermatol 131:514–520CrossRefPubMed
22.
Zurück zum Zitat Szekeres G, De Giacomoni P (1994) Ki-67 and p53 expression in cutaneous bowen’s disease: an immunohistochemical study of fixed-embedded tissue sections. Acta Derm Venereol 74:95–97PubMed Szekeres G, De Giacomoni P (1994) Ki-67 and p53 expression in cutaneous bowen’s disease: an immunohistochemical study of fixed-embedded tissue sections. Acta Derm Venereol 74:95–97PubMed
23.
Zurück zum Zitat Takedai T, Yamamoto I, Tokeshi J (2003) Acute generalized pustular psoriasis presenting with erythroderma associated with shock and acute renal failure. Hawaii Med J 62:278–281PubMed Takedai T, Yamamoto I, Tokeshi J (2003) Acute generalized pustular psoriasis presenting with erythroderma associated with shock and acute renal failure. Hawaii Med J 62:278–281PubMed
24.
Zurück zum Zitat Terui T, Ozawa M, Tagami H (2000) Role of neutrophils in induction of acute inflammation in t-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop. Exp Dermatol 9:1–10CrossRefPubMed Terui T, Ozawa M, Tagami H (2000) Role of neutrophils in induction of acute inflammation in t-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop. Exp Dermatol 9:1–10CrossRefPubMed
25.
Zurück zum Zitat Yazici AC, Tursen U, Apa DD, Ikizoglu G, Api H, Baz K, Tasdelen B (2005) The changes in expression of icam-3, ki-67, pcna, and cd31 in psoriatic lesions before and after methotrexate treatment. Arch Dermatol Res 297:249–255CrossRefPubMed Yazici AC, Tursen U, Apa DD, Ikizoglu G, Api H, Baz K, Tasdelen B (2005) The changes in expression of icam-3, ki-67, pcna, and cd31 in psoriatic lesions before and after methotrexate treatment. Arch Dermatol Res 297:249–255CrossRefPubMed
Metadaten
Titel
A comparison of Ki-67 antigen presentation in acute generalized exanthematous pustulosis and pustular psoriasis
verfasst von
Shyue-Luen Chang
Sindy Hu
Shuen-Iu Hung
Yau-Li Huang
Wen-chin Hsiao
Wen-Hung Chung
Publikationsdatum
01.09.2010
Verlag
Springer-Verlag
Erschienen in
Archives of Dermatological Research / Ausgabe 7/2010
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-010-1046-3

Weitere Artikel der Ausgabe 7/2010

Archives of Dermatological Research 7/2010 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.